COVID and VITT Webinar

At the end of this session, you will be able to:
Explain the pathophysiology of COVID-19 in relation to thrombosis, including bronchoalveolar hemostasis, pulmonary thrombosis, and viral endotheliaopathy
Describe how COVID-19–related thrombosis is diagnosed
and treated
Explain what D-dimers and platelet counts tell us about the pathophysiology of COVID-19.
Explain the relationship between the COVID-19 vaccine and VITT
Describe the features and management of VITT

Please Note: The information presented here is meant for educational purposes only. It does not represent any treatment or therapy recommendation.

Dr. Jecko Thachil, MD is an honorary consultant in haemostasis and thrombosis at Manchester Royal Infirmary Hospital and clinical academic professor of infection and global health at the University of Manchester, UK. He is a member of the Subcommittee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Hemostasis and is the editor of the journal Physicians' Information and Education Resource for the American College of Physicians. He is the author of more than 70 publications in specialized journals and co-author of the guideline on DIC of the British Committee for Standards in Hematology.